DB
Danielle Brill Truist Securities Latest Price Targets & Analyst Ratings
Main Sector
Healthcare
Ratings Past Year
28
Avg Return
Past Year
Past Year
17%
Success Rate
Past Year
Past Year
0
%
Rating Distribution
Past 3 Months
Positive
92.3%
Neutral
7.7%
Negative
0%
Past Week
Past Month
Past 3 Months
Past 6 Months
Past Year
All Time
Positive
Neutral
Negative
Large Cap
$10B to $200B
Mid Cap
$2B to $10B
Small Cap
$250M to $2B
Micro Cap
Under $250M
Financials
Healthcare
Financials
Credit Services
Healthcare
Biotechnology
Drug Manufacturers - General
Drug Manufacturers - Specialty & Generic
| Stock | Rating | Price Target |
Upside Downside |
Ratings 3 Months |
Avg Return 1 Year |
Success Rate 1 Year | Date | |
|---|---|---|---|---|---|---|---|---|
|
Buy
Maintained
| $60 |
219%
upside
| 1 | -7.1% |
0
%
| 8 Jan ‘26 10 days ago |
|
|
|
Buy
Maintained
| $169 |
28%
upside
| 2 | +0.19% |
0
%
| 8 Jan ‘26 10 days ago |
|
|
|
Hold
Maintained
| $22 |
16%
downside
| 1 | -42% |
–
| 8 Jan ‘26 10 days ago |
|
|
|
Buy
Maintained
| $45 |
24%
upside
| 1 | +1.6% |
0
%
| 8 Jan ‘26 10 days ago |
|
|
|
Buy
Maintained
| $63 |
43%
upside
| 1 | +13% |
0
%
| 8 Jan ‘26 10 days ago |
|
|
|
Buy
Maintained
| $33 |
49%
upside
| 1 | +21% |
0
%
| 8 Jan ‘26 10 days ago |
|
|
|
Buy
Maintained
| $86 |
13%
upside
| 2 | +19% |
0
%
| 8 Jan ‘26 10 days ago |
|
|
|
Buy
Maintained
| $530 |
48%
upside
| 1 | +7.6% |
0
%
| 8 Jan ‘26 10 days ago |
|
|
|
Buy
Maintained
| $190 |
91%
upside
| 2 | +41% |
0
%
| 16 Dec ‘25 1 month ago |
|
|
|
Buy
Maintained
| $114 |
61%
upside
| 1 | +15% |
0
%
| 10 Nov ‘25 2 months ago |
|